Go Pro

Ultralife (ULBI) Competitors

Ultralife logo
$5.32 +0.01 (+0.19%)
Closing price 08/6/2026 04:00 PM Eastern
Extended Trading
$5.66 +0.35 (+6.48%)
As of 08/6/2026 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ULBI vs. NPWR, MVST, SES, EAF, and RONI

Should you buy Ultralife stock or one of its competitors? MarketBeat compares Ultralife with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ultralife include NET Power (NPWR), Microvast (MVST), SES AI (SES), GrafTech International (EAF), and Rice Acquisition Corp. II (RONI).

How does Ultralife compare to NET Power?

Ultralife (NASDAQ:ULBI) and NET Power (NYSE:NPWR) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

30.7% of Ultralife shares are held by institutional investors. Comparatively, 53.6% of NET Power shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 2.1% of NET Power shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

NET Power has a net margin of 0.00% compared to Ultralife's net margin of -4.37%. NET Power's return on equity of 133.74% beat Ultralife's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
NET Power N/A 133.74%43.90%

NET Power has a consensus price target of $3.50, suggesting a potential upside of 134.11%. Given NET Power's stronger consensus rating and higher possible upside, analysts clearly believe NET Power is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NET Power
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Ultralife has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, NET Power has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market.

Ultralife has higher revenue and earnings than NET Power. Ultralife is trading at a lower price-to-earnings ratio than NET Power, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$187.86M0.47-$5.90M-$0.50N/A
NET Power$250K1,342.03-$578.63M-$5.89N/A

In the previous week, NET Power had 10 more articles in the media than Ultralife. MarketBeat recorded 11 mentions for NET Power and 1 mentions for Ultralife. NET Power's average media sentiment score of 0.48 beat Ultralife's score of 0.00 indicating that NET Power is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NET Power
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

NET Power beats Ultralife on 12 of the 16 factors compared between the two stocks.

How does Ultralife compare to Microvast?

Ultralife (NASDAQ:ULBI) and Microvast (NASDAQ:MVST) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Ultralife has higher earnings, but lower revenue than Microvast. Ultralife is trading at a lower price-to-earnings ratio than Microvast, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$187.86M0.47-$5.90M-$0.50N/A
Microvast$427.52M0.61-$29.22M-$0.32N/A

Ultralife has a net margin of -4.37% compared to Microvast's net margin of -11.52%. Ultralife's return on equity of 1.15% beat Microvast's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
Microvast -11.52%-6.12%-2.43%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Microvast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

30.7% of Ultralife shares are held by institutional investors. Comparatively, 20.7% of Microvast shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 44.8% of Microvast shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Microvast had 19 more articles in the media than Ultralife. MarketBeat recorded 20 mentions for Microvast and 1 mentions for Ultralife. Microvast's average media sentiment score of 0.09 beat Ultralife's score of 0.00 indicating that Microvast is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microvast
2 Very Positive mention(s)
0 Positive mention(s)
17 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Ultralife has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Microvast has a beta of 3.55, indicating that its stock price is 255% more volatile than the broader market.

Summary

Microvast beats Ultralife on 9 of the 14 factors compared between the two stocks.

How does Ultralife compare to SES AI?

SES AI (NYSE:SES) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

29.8% of SES AI shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 13.8% of SES AI shares are held by company insiders. Comparatively, 42.9% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

SES AI has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

Ultralife has a net margin of -4.37% compared to SES AI's net margin of -331.72%. Ultralife's return on equity of 1.15% beat SES AI's return on equity.

Company Net Margins Return on Equity Return on Assets
SES AI-331.72% -28.65% -23.21%
Ultralife -4.37%1.15%0.70%

In the previous week, SES AI had 4 more articles in the media than Ultralife. MarketBeat recorded 5 mentions for SES AI and 1 mentions for Ultralife. SES AI's average media sentiment score of 0.25 beat Ultralife's score of 0.00 indicating that SES AI is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SES AI
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SES AI currently has a consensus target price of $2.70, suggesting a potential upside of 434.65%. Given SES AI's stronger consensus rating and higher probable upside, analysts plainly believe SES AI is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SES AI
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ultralife has higher revenue and earnings than SES AI. Ultralife is trading at a lower price-to-earnings ratio than SES AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SES AI$21M8.82-$73.04M-$0.22N/A
Ultralife$187.86M0.47-$5.90M-$0.50N/A

Summary

SES AI beats Ultralife on 9 of the 16 factors compared between the two stocks.

How does Ultralife compare to GrafTech International?

GrafTech International (NYSE:EAF) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

92.8% of GrafTech International shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 1.2% of GrafTech International shares are held by insiders. Comparatively, 42.9% of Ultralife shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Ultralife has lower revenue, but higher earnings than GrafTech International. Ultralife is trading at a lower price-to-earnings ratio than GrafTech International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GrafTech International$504.13M0.40-$219.84M-$6.80N/A
Ultralife$187.86M0.47-$5.90M-$0.50N/A

GrafTech International has a beta of 1.83, meaning that its stock price is 83% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

GrafTech International presently has a consensus price target of $10.67, suggesting a potential upside of 39.25%. Given GrafTech International's stronger consensus rating and higher probable upside, equities analysts plainly believe GrafTech International is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GrafTech International
3 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ultralife has a net margin of -4.37% compared to GrafTech International's net margin of -34.58%. Ultralife's return on equity of 1.15% beat GrafTech International's return on equity.

Company Net Margins Return on Equity Return on Assets
GrafTech International-34.58% N/A -17.50%
Ultralife -4.37%1.15%0.70%

In the previous week, GrafTech International had 1 more articles in the media than Ultralife. MarketBeat recorded 2 mentions for GrafTech International and 1 mentions for Ultralife. GrafTech International's average media sentiment score of 1.17 beat Ultralife's score of 0.00 indicating that GrafTech International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GrafTech International
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

GrafTech International beats Ultralife on 8 of the 15 factors compared between the two stocks.

How does Ultralife compare to Rice Acquisition Corp. II?

Ultralife (NASDAQ:ULBI) and Rice Acquisition Corp. II (NYSE:RONI) are related small-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Rice Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Rice Acquisition Corp. II has lower revenue, but higher earnings than Ultralife.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$187.86M0.47-$5.90M-$0.50N/A
Rice Acquisition Corp. IIN/AN/A$4.07MN/AN/A

Ultralife has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Rice Acquisition Corp. II has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

Rice Acquisition Corp. II has a net margin of 0.00% compared to Ultralife's net margin of -4.37%. Ultralife's return on equity of 1.15% beat Rice Acquisition Corp. II's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
Rice Acquisition Corp. II N/A -17.93%-4.49%

In the previous week, Ultralife had 1 more articles in the media than Rice Acquisition Corp. II. MarketBeat recorded 1 mentions for Ultralife and 0 mentions for Rice Acquisition Corp. II. Ultralife's average media sentiment score of 0.00 equaled Rice Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Ultralife Neutral
Rice Acquisition Corp. II Neutral

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 22.5% of Rice Acquisition Corp. II shares are owned by institutional investors. 42.9% of Ultralife shares are owned by company insiders. Comparatively, 20.0% of Rice Acquisition Corp. II shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Ultralife beats Rice Acquisition Corp. II on 8 of the 10 factors compared between the two stocks.

Get Ultralife News Delivered to You Automatically

Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ULBI vs. The Competition

MetricUltralifeElectrical Equipment IndustryIndustrials SectorNASDAQ Exchange
Market Cap$88.45M$11.06B$10.83B$12.87B
Dividend YieldN/A2.31%120.64%9.93%
P/E Ratio-10.6449.5428.4025.30
Price / Sales0.471,592.32317.6882.44
Price / Cash8.8230.5324.9150.37
Price / Book0.685.144.516.13
Net Income-$5.90M$135.44M$607.47M$342.95M
7 Day Performance2.50%3.61%2.88%3.19%
1 Month Performance-11.04%-7.02%0.47%-1.98%
1 Year Performance-21.42%23.94%13.70%21.11%

Ultralife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ULBI
Ultralife
1.0531 of 5 stars
$5.32
+0.2%
N/A-34.8%$88.45M$187.86MN/A560
NPWR
NET Power
1.9044 of 5 stars
$1.43
-1.7%
$3.50
+145.6%
-44.3%$325.40M$250KN/A24
MVST
Microvast
1.2845 of 5 stars
$0.77
-4.2%
N/A-70.0%$267.39M$427.52MN/A1,908
SES
SES AI
2.4418 of 5 stars
$0.53
-4.2%
$2.70
+407.5%
-52.6%$203.62M$21MN/A130
EAF
GrafTech International
2.1599 of 5 stars
$7.64
-2.0%
$10.67
+39.7%
-34.2%$203.26M$504.13MN/A1,071

Related Companies and Tools


This page (NASDAQ:ULBI) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners